Peripheral arterial disease

PREVIEW Peripheral arterial disease of the lower extremities is a common manifestation of the atherosclerotic process. A heightened awareness of symptomatic and asymptomatic disease, as well as screening of at-risk patients, is imperative because of the increased risk of cardiovascular disease, cerebrovascular disease, and even death. This article describes the various symptoms, diagnostic tests, and therapies for this common, underdiagnosed, undertreated disease.

[1]  Patrice Cacoub,et al.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. , 2006, The New England journal of medicine.

[2]  B. Gersh,et al.  Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. , 2004, Mayo Clinic proceedings.

[3]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[4]  S. Yusuf,et al.  Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. , 2004, European heart journal.

[5]  J. Regensteiner,et al.  Exercise training for claudication. , 2002, The New England journal of medicine.

[6]  K. Eagle,et al.  Missed Opportunities to Treat Atherosclerosis in Patients Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2) , 2002, Circulation.

[7]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[8]  M. Criqui,et al.  Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .

[9]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[10]  M J Koelemay,et al.  Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. , 2001, JAMA.

[11]  M. Criqui.  Peripheral arterial disease - epidemiological aspects , 2001, Vascular medicine.

[12]  D. Dawson,et al.  A comparison of cilostazol and pentoxifylline for treating intermittent claudication. , 2000, The American journal of medicine.

[13]  S. Rose.  Noninvasive vascular laboratory for evaluation of peripheral arterial occlusive disease: Part II--clinical applications: chronic, usually atherosclerotic, lower extremity ischemia. , 2000, Journal of vascular and interventional radiology : JVIR.

[14]  J. Dormandy,et al.  The fate of patients with critical leg ischemia. , 1999, Seminars in vascular surgery.

[15]  N. Powe,et al.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[16]  E. Boyko,et al.  Physical examination and chronic lower-extremity ischemia: a critical review. , 1998, Archives of internal medicine.

[17]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[18]  T. Bunt,et al.  A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems. , 1995, Journal of vascular surgery.

[19]  R. Barnes.  Noninvasive Diagnostic Assessment of Peripheral Vascular Disease , 1991, Circulation.

[20]  D. Gillings,et al.  Another Look at the Pentoxifylline Efficacy Data for Intermittent Claudication , 1987, Journal of clinical pharmacology.

[21]  R. Hobson,et al.  The value of laser Doppler velocimetry and transcutaneous oxygen tension determination in predicting healing of ischemic forefoot ulcerations and amputations in diabetic and nondiabetic patients. , 1986, Journal of vascular surgery.

[22]  J. Myers,et al.  The Role of Vascular Laboratory Criteria in the Selection of Patients for Lower Extremity Amputation , 1982, Annals of surgery.

[23]  R. Barnes,et al.  Minor forefoot amputation in patients with low ankle pressure. , 1977, American journal of surgery.

[24]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[25]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[26]  J. Cooke,et al.  Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. , 1998, Advances in internal medicine.

[27]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[28]  A. Fronek,et al.  Oxygen inhalation--induced transcutaneous PO2 changes as a predictor of amputation level. , 1985, Journal of vascular surgery.

[29]  S. Carter.  The relationship of distal systolic pressures to healing of skin lesions in limbs with arterial occlusive disease, with special reference to diabetes mellitus. , 1973, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[30]  Carter Sa.  The relationship of distal systolic pressures to healing of skin lesions in limbs with arterial occlusive disease, with special reference to diabetes mellitus. , 1973 .